On-Demand Webcast


Program Content

  • Evolving Tx for HER2+ BC
    Mastering the Evolving Treatment Landscape in HER2-Positive Breast Cancer: Current Guidance and Future Perspectives
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 24, 2022

    Expires: March 23, 2023

    View Activity


cover img faculity

Aditya Bardia, MD, MPH

Director, Breast Cancer Research
Associate Professor
Harvard Medical School
Attending Physician
Massachusetts General Hospital
Boston, Massachusetts

cover img faculity

Claudine Isaacs, MD

Professor of Medicine and Oncology
Associate Director for Clinical Research
Georgetown University
Washington, DC

cover img faculity

David B. Page, MD

Assistant Member, Medical Oncology
Medical Oncologist
Providence Cancer Institute
Providence Health & Services
Portland, Oregon

Provided by

ProCE Banner


Puma Biotechnology, Inc.

Seagen Inc.